The full arc, 2023 → 2027, designations, the Category-2 removal, the July PCAC catalyst, and the projected rulemaking. One source of truth, three ways to read it.
Dates verified to July 26, 2026. PCAC is advisory, a favorable vote leads to rulemaking, not instant availability. Compounded medications are not FDA-approved.